• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surgery for primary hyperparathyroidism in Germany, Switzerland, and Austria: an analysis of data from the EUROCRINE registry.德国、瑞士和奥地利原发性甲状旁腺功能亢进症的手术治疗:来自 EUROCRINE 注册中心的数据分析。
Langenbecks Arch Surg. 2023 Apr 13;408(1):150. doi: 10.1007/s00423-023-02819-2.
2
[EUROCRINE®: adrenal surgery 2015-2019- surprising initial results].[EUROCRINE®:2015 - 2019年肾上腺手术——出人意料的初步结果]
Chirurg. 2021 May;92(5):448-463. doi: 10.1007/s00104-020-01277-6.
3
Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).原发性甲状旁腺功能亢进和肾性甲状旁腺功能亢进的治疗:德国内分泌外科学会(CAEK)指南。
Langenbecks Arch Surg. 2021 May;406(3):571-585. doi: 10.1007/s00423-021-02173-1. Epub 2021 Apr 21.
4
Surgical treatment in patients with single and multiple gland primary hyperparathyroidism with the use of intraoperative parathyroid hormone monitoring: extensive single-center experience.术中甲状旁腺激素监测在单发和多发甲状旁腺功能亢进症患者手术治疗中的应用:广泛的单中心经验。
Hormones (Athens). 2019 Sep;18(3):273-279. doi: 10.1007/s42000-019-00121-9. Epub 2019 Jul 22.
5
Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.术中甲状旁腺监测(ioPTH)预测多腺体或恶性甲状旁腺疾病的有效性。
Int J Surg. 2017 May;41 Suppl 1:S26-S33. doi: 10.1016/j.ijsu.2017.02.063.
6
Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.术中甲状旁腺激素监测对原发性甲状旁腺功能亢进症患者管理的影响。
Clin Endocrinol (Oxf). 2019 Feb;90(2):277-284. doi: 10.1111/cen.13882. Epub 2018 Nov 19.
7
Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.原发性甲状旁腺功能亢进症中 F18-胆碱 PET/CT 与 Tc99m- sestamibi SPECT/CT 引导手术的前瞻性比较:APACH2 随机 III 期诊断试验
BMC Endocr Disord. 2021 Jan 7;21(1):3. doi: 10.1186/s12902-020-00667-5.
8
[Unicentre Results in Surgery of Primary Hyperparathyroidism with Postoperative Long-Term Follow-Up and Value of Intraoperative Quick Parathormone Test].[原发性甲状旁腺功能亢进症手术的单中心结果及术后长期随访与术中快速甲状旁腺素检测的价值]
Zentralbl Chir. 2016 Apr;141(2):175-82. doi: 10.1055/s-0034-1368541. Epub 2014 Oct 21.
9
Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.现代技术对原发性甲状旁腺功能亢进症手术后短期结局的影响:一项纳入2708例患者的多中心研究。
Langenbecks Arch Surg. 2009 Sep;394(5):851-60. doi: 10.1007/s00423-009-0540-6. Epub 2009 Jul 18.
10
SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021.奥地利、德国和瑞士的 SPECT 和 PET 心肌灌注成像:2021 年首次联合调查结果。
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3602-3608. doi: 10.1007/s00259-023-06336-8. Epub 2023 Jul 15.

引用本文的文献

1
Perioperative characteristics and short-term morbidity after surgery for renal hyperparathyroidism: multicentre EUROCRINE® registry study.肾性甲状旁腺功能亢进症手术后的围手术期特征和短期发病率:多中心EUROCRINE®注册研究
BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf048.
2
Is intraoperative parathyroid monitoring during minimally invasive parathyroidectomy still justified?微创甲状旁腺切除术时行术中甲状旁腺监测是否仍有必要?
Front Endocrinol (Lausanne). 2024 Jul 22;15:1442972. doi: 10.3389/fendo.2024.1442972. eCollection 2024.
3
Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, Gene-Related Tumors, and Insulin Resistance.原发性甲状旁腺功能亢进及其胰腺受累的跨学科转折点:高钙血症性胰腺炎、基因相关性肿瘤和胰岛素抵抗。
Int J Mol Sci. 2024 Jun 8;25(12):6349. doi: 10.3390/ijms25126349.
4
Endocrinology application of molecular imaging: current role of PET/CT.分子影像学在内分泌学中的应用:PET/CT 的当前作用。
J Endocrinol Invest. 2024 Oct;47(10):2383-2396. doi: 10.1007/s40618-024-02400-8. Epub 2024 Jun 5.

本文引用的文献

1
Accessing the influence of Tc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism.探讨原发性甲状旁腺功能亢进患者 Tc-Sesta-MIBI 阳性甲状腺结节对术前定位研究的影响。
Langenbecks Arch Surg. 2022 May;407(3):1183-1191. doi: 10.1007/s00423-022-02442-7. Epub 2022 Jan 21.
2
Diagnostic Performance of Cervical Ultrasound, Tc-Sestamibi Scintigraphy, and Contrast-Enhanced F-Fluorocholine PET in Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症中颈超声、Tc-Sestamibi 闪烁扫描及 F-Fluorocholine PET 对比增强的诊断性能。
J Nucl Med. 2022 Jul;63(7):1081-1086. doi: 10.2967/jnumed.121.261900. Epub 2021 Dec 2.
3
European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism.欧洲多国多中心研究孤立性原发性甲状旁腺功能亢进症手术治疗结果。
Br J Surg. 2021 Jun 22;108(6):675-683. doi: 10.1002/bjs.12025.
4
Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults.术中甲状旁腺激素监测(IOPTH)和术前影像学引导下的微创甲状旁腺切除术与双侧颈部探查治疗成人原发性甲状旁腺功能亢进症的比较
Cochrane Database Syst Rev. 2020 Oct 21;10(10):CD010787. doi: 10.1002/14651858.CD010787.pub2.
5
[Thyroid nodules: The Guidelines of the American Thyroid Association from a European Perspective].[甲状腺结节:从欧洲视角看美国甲状腺协会指南]
Dtsch Med Wochenschr. 2020 Aug;145(17):1227-1235. doi: 10.1055/a-1018-2767. Epub 2020 Jul 7.
6
Surgical implications of recent modalities for parathyroid imaging.甲状旁腺成像近期方法的手术意义
Gland Surg. 2020 Feb;9(Suppl 2):S86-S94. doi: 10.21037/gs.2019.11.10.
7
Reoperation for Bleeding After Thyroid and Parathyroid Surgery: Incidence, Risk Factors, Prevention, and Management.甲状腺和甲状旁腺手术后出血的再次手术:发生率、危险因素、预防和处理。
World J Surg. 2020 Apr;44(4):1156-1162. doi: 10.1007/s00268-019-05322-2.
8
F-Fluorocholine PET/CT in Primary Hyperparathyroidism: Superior Diagnostic Performance to Conventional Scintigraphic Imaging for Localization of Hyperfunctioning Parathyroid Glands.氟代胆碱正电子发射断层扫描/计算机断层扫描在原发性甲状旁腺功能亢进症中的应用:对异位甲状旁腺功能亢进的定位诊断优于传统显像。
J Nucl Med. 2020 Apr;61(4):577-583. doi: 10.2967/jnumed.119.229914. Epub 2019 Sep 27.
9
The diagnostic value of parathyroid hormone washout in primary hyperparathyroidism patients with negative or equivocal 99 m Tc-MIBI results.甲状旁腺激素洗脱在99m Tc-MIBI结果为阴性或不确定的原发性甲状旁腺功能亢进患者中的诊断价值。
Diagn Cytopathol. 2019 Feb;47(2):94-99. doi: 10.1002/dc.24065. Epub 2018 Nov 21.
10
Primary hyperparathyroidism.原发性甲状旁腺功能亢进症。
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):593-607. doi: 10.1016/j.beem.2018.09.004. Epub 2018 Sep 22.

德国、瑞士和奥地利原发性甲状旁腺功能亢进症的手术治疗:来自 EUROCRINE 注册中心的数据分析。

Surgery for primary hyperparathyroidism in Germany, Switzerland, and Austria: an analysis of data from the EUROCRINE registry.

机构信息

Division of Visceral Surgery, Department of General Surgery, Medical University Vienna, Vienna, Austria.

Department of Surgery, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

出版信息

Langenbecks Arch Surg. 2023 Apr 13;408(1):150. doi: 10.1007/s00423-023-02819-2.

DOI:10.1007/s00423-023-02819-2
PMID:37055669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10102096/
Abstract

PURPOSE

EUROCRINE is an endocrine surgical register documenting diagnostic processes, indication for surgical treatment, surgical procedures, and outcomes. The purpose was to analyse data for PHPT in German speaking countries regarding differences in clinical presentation, diagnostic workup, and treatment.

METHODS

All operations for PHPT performed from 07/2015 to 12/2019 were analysed.

RESULTS

Three thousand two hundred ninety-one patients in Germany (9 centres; 1762 patients), Switzerland (16 centres; 971 patients) and Austria (5 centres; 558 patients) were analysed. Hereditary disease was seen in 36 patients in Germany, 16 patients in Switzerland and 8 patients in Austria. In sporadic disease before primary operation, PET-CT showed the highest sensitivity in all countries. In re-operations, CT and PET-CT achieved the highest sensitivities. The highest sensitivity of IOPTH was seen in Austria (98.1%), followed by Germany (96.4%) and Switzerland (91.3%). Operation methods and mean operative time reached statistical significance (p<0.05). Complication rates are low. Overall, 656 (19.9%) patients were asymptomatic; the remainder showed bone manifestations, kidney stones, fatigue and/or neuropsychiatric symptoms.

CONCLUSION

Early postoperative normocalcaemia ranged between 96.8 and 97.1%. Complication rates are low. PET-CT had the highest sensitivity in all three countries in patients undergoing primary operation as well as in Switzerland and Austria in patients undergoing re-operation. PET-CT could be considered a first-line preoperative imaging modality in patients with inconclusive ultrasound examination. The EUROCRINE registry is a beneficial and comprehensive data source for outcome analysis of endocrine procedures on a supranational level.

摘要

目的

EUROCRINE 是一个内分泌外科登记处,记录诊断过程、手术治疗指征、手术程序和结果。目的是分析德语国家 PHPT 的数据,了解临床表型、诊断评估和治疗方面的差异。

方法

分析了 2015 年 7 月至 2019 年 12 月期间进行的所有 PHPT 手术。

结果

在德国(9 个中心;1762 例患者)、瑞士(16 个中心;971 例患者)和奥地利(5 个中心;558 例患者)分析了 3291 例患者。德国有 36 例遗传性疾病,瑞士有 16 例,奥地利有 8 例。在初次手术前的散发性疾病中,PET-CT 在所有国家的敏感性最高。在再次手术中,CT 和 PET-CT 的敏感性最高。IOPTH 的敏感性最高的是奥地利(98.1%),其次是德国(96.4%)和瑞士(91.3%)。手术方法和平均手术时间具有统计学意义(p<0.05)。并发症发生率低。总的来说,656 例(19.9%)患者无症状;其余患者表现为骨表现、肾结石、疲劳和/或神经精神症状。

结论

术后早期血钙正常范围在 96.8%至 97.1%之间。并发症发生率低。在初次手术和瑞士、奥地利再次手术中,PET-CT 在所有三个国家的敏感性最高。在超声检查结果不确定的患者中,PET-CT 可作为一线术前影像学检查方法。EUROCRINE 登记处是在跨国层面上分析内分泌手术结果的有益且全面的数据源。